Skip to main content
Top

Diabetology International

Issue 1/2016

Content (15 Articles)

Editorial

Diabetic nephropathy and transcription factors

Yuichi Makino, Masakazu Haneda

Report of the committee

A large-scale observational study to investigate the current status of diabetes complications and their prevention in Japan: research outline and baseline data for type 1 diabetes—JDCP study 2

Rimei Nishimura, Kazuo Izumi, Yasuaki Hayashino, Hideki Origasa, Mitsuhiko Noda, Kohjiro Ueki, Naoko Tajima

Report of the committee

Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer, Second Report

Atsushi Goto, Hiroshi Noto, Mitsuhiko Noda, Kohjiro Ueki, Masato Kasuga, Naoko Tajima, Ken Ohashi, Ryuichi Sakai, Shoichiro Tsugane, Nobuyuki Hamajima, Kazuo Tajima, Kohzoh Imai, Hitoshi Nakagama

Original Article

Decreased glucagon levels and decreased insulin secretion after sitagliptin versus mitiglinide administration with similar glycemic levels following an oral glucose load: a randomized crossover pharmaceutical mechanistic study

Yoshitaka Akiyama, Tomoko Morita-Ohkubo, Natsuko Oshitani, Yuko Ohno, Yoshimasa Aso, Toshihiko Inukai, Masafumi Kakei, Masanobu Kawakami, Takuya Awata, Shigehiro Katayama, Masafumi Matsuda

Original Article

Non-high-density cholesterol level as a predictor of maximum carotid intima-media thickness in Japanese subjects with type 2 diabetes: a comparison with low-density lipoprotein level

Yukihiro Bando, Hitomi Wakaguri, Keiko Aoki, Hideo Kanehara, Azusa Hisada, Kazuhiro Okafuji, Daisyu Toya, Nobuyoshi Tanaka

Original Article

Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin-dependent (type 1) diabetes (SPIDDM)

Shoichiro Tanaka, Minoru Okubo, Kaoru Nagasawa, Soichi Takizawa, Masashi Ichijo, Sayaka Ichijo, Masahiro Kaneshige, Kaoru Aida, Hiroki Shimura, Yasumichi Mori, Tetsuro Kobayashi

Original Article

Glucose area under the curve during oral glucose tolerance test as an index of glucose intolerance

Kazuhiko Sakaguchi, Kazuo Takeda, Mitsuo Maeda, Wataru Ogawa, Toshiyuki Sato, Seiki Okada, Yasuhito Ohnishi, Hiromu Nakajima, Atsunori Kashiwagi

Original Article

Deletion of SIRT1 in myeloid cells impairs glucose metabolism with enhancing inflammatory response to adipose tissue hypoxia

Akiko Takikawa, Isao Usui, Shiho Fujisaka, Masashi Ikutani, Satoko Senda, Shinpei Hattori, Koichi Tsuneyama, Yukiko Koshimizu, Ran Inoue, Ayumi Tanaka-Hayashi, Takashi Nakagawa, Yoshinori Nagai, Kiyoshi Takatsu, Toshiyasu Sasaoka, Hisashi Mori, Kazuyuki Tobe

Original Article

Association between symptoms of bilateral numbness and/or paresthesia in the feet and postural instability in Japanese patients with diabetes

Akiko Morimoto, Nao Sonoda, Satoshi Ugi, Katsutaro Morino, Osamu Sekine, Ken-ichi Nemoto, Mihoko Ogita, Yukako Tatsumi, Shin Murata, Hiroshi Maegawa, Naomi Miyamatsu

Short Communication

Association between attentional function and postural instability in Japanese older patients with diabetes mellitus

Akiko Morimoto, Nao Sonoda, Satoshi Ugi, Katsutaro Morino, Osamu Sekine, Ken-ichi Nemoto, Mihoko Ogita, Yukako Tatsumi, Shin Murata, Hiroshi Maegawa, Naomi Miyamatsu

Case Report

A case of glucocorticoid-induced diabetes in which the efficacy between sitagliptin and metformin was compared

Chisaki Ishibashi, Tetsuyuki Yasuda, Taka-aki Matsuoka, Koichi Hirai, Fumie Sakamoto, Tetsuhiro Kitamura, Junji Kozawa, Michio Otsuki, Tohru Funahashi, Akihisa Imagawa, Hideaki Kaneto, Iichiro Shimomura

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine